Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes
(2009) In Diabetic Medicine 26(3). p.211-219- Abstract
- To investigate the effect of oral calcium (Ca2+) supplementation on insulin sensitivity measured by the euglycaemic hyperinsulinaemic clamp, intraplatelet cationic concentration of Ca2+ ([Ca2+](i)) and the transmembrane sodium-hydrogen exchanger (NHE) activity in erythrocytes in subjects with Type 2 diabetes and hypertension. In this parallel randomized controlled single-blinded trial, 31 patients were allocated to receive either 1500 mg of Ca2+ orally, daily (n = 15) or no treatment (n = 16) for 8 weeks. At baseline and at the end of the 8-week period insulin sensitivity, [Ca2+](i) and the first isoform of NHE (NHE-1) activity were measured. At the end of the study, subjects who received Ca2+ supplementation showed higher insulin... (More)
- To investigate the effect of oral calcium (Ca2+) supplementation on insulin sensitivity measured by the euglycaemic hyperinsulinaemic clamp, intraplatelet cationic concentration of Ca2+ ([Ca2+](i)) and the transmembrane sodium-hydrogen exchanger (NHE) activity in erythrocytes in subjects with Type 2 diabetes and hypertension. In this parallel randomized controlled single-blinded trial, 31 patients were allocated to receive either 1500 mg of Ca2+ orally, daily (n = 15) or no treatment (n = 16) for 8 weeks. At baseline and at the end of the 8-week period insulin sensitivity, [Ca2+](i) and the first isoform of NHE (NHE-1) activity were measured. At the end of the study, subjects who received Ca2+ supplementation showed higher insulin sensitivity (Delta M-value 0.32 +/- 0.5 mmol/min P < 0.05) and lower [Ca2+](i) (125.0 +/- 24.7 to 80.4 +/- 10.6 nmol/l, P < 0.05, mean +/- sem) and NHE-1 activity (79.5 +/- 10.0 to 52.1 +/- 6.4 mmol Na/l red cell/h, P < 0.05). None of the above parameters were changed in the control group. Simple regression analysis demonstrated the change in [Ca2+](i) significantly determined insulin sensitivity change (beta = -0.36, P < 0.05). Oral Ca2+ supplementation improves insulin sensitivity in patients with Type 2 diabetes and hypertension. These changes are likely to be mediated by changes in intracellular ionic Ca2+. NHE-1 activity was also reduced after Ca2+ supplementation but its role in insulin sensitivity requires further investigation. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1404945
- author
- Pikilidou, M. I. ; Lasaridis, A. N. ; Sarafidis, P. A. ; Befani, C. D. ; Koliakos, G. G. ; Tziolas, I. M. ; Kazakos, K. A. ; Yovos, J. G. and Nilsson, Peter LU
- organization
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- calcium supplementation, hyperinsulinaemic clamp, insulin sensitivity
- in
- Diabetic Medicine
- volume
- 26
- issue
- 3
- pages
- 211 - 219
- publisher
- Wiley-Blackwell
- external identifiers
-
- wos:000264163800003
- scopus:62449232030
- pmid:19317814
- ISSN
- 1464-5491
- DOI
- 10.1111/j.1464-5491.2009.02673.x
- language
- English
- LU publication?
- yes
- id
- b9260dbf-76f9-499d-92af-601389ae2dcf (old id 1404945)
- date added to LUP
- 2016-04-01 14:38:25
- date last changed
- 2022-01-28 01:46:57
@article{b9260dbf-76f9-499d-92af-601389ae2dcf, abstract = {{To investigate the effect of oral calcium (Ca2+) supplementation on insulin sensitivity measured by the euglycaemic hyperinsulinaemic clamp, intraplatelet cationic concentration of Ca2+ ([Ca2+](i)) and the transmembrane sodium-hydrogen exchanger (NHE) activity in erythrocytes in subjects with Type 2 diabetes and hypertension. In this parallel randomized controlled single-blinded trial, 31 patients were allocated to receive either 1500 mg of Ca2+ orally, daily (n = 15) or no treatment (n = 16) for 8 weeks. At baseline and at the end of the 8-week period insulin sensitivity, [Ca2+](i) and the first isoform of NHE (NHE-1) activity were measured. At the end of the study, subjects who received Ca2+ supplementation showed higher insulin sensitivity (Delta M-value 0.32 +/- 0.5 mmol/min P < 0.05) and lower [Ca2+](i) (125.0 +/- 24.7 to 80.4 +/- 10.6 nmol/l, P < 0.05, mean +/- sem) and NHE-1 activity (79.5 +/- 10.0 to 52.1 +/- 6.4 mmol Na/l red cell/h, P < 0.05). None of the above parameters were changed in the control group. Simple regression analysis demonstrated the change in [Ca2+](i) significantly determined insulin sensitivity change (beta = -0.36, P < 0.05). Oral Ca2+ supplementation improves insulin sensitivity in patients with Type 2 diabetes and hypertension. These changes are likely to be mediated by changes in intracellular ionic Ca2+. NHE-1 activity was also reduced after Ca2+ supplementation but its role in insulin sensitivity requires further investigation.}}, author = {{Pikilidou, M. I. and Lasaridis, A. N. and Sarafidis, P. A. and Befani, C. D. and Koliakos, G. G. and Tziolas, I. M. and Kazakos, K. A. and Yovos, J. G. and Nilsson, Peter}}, issn = {{1464-5491}}, keywords = {{calcium supplementation; hyperinsulinaemic clamp; insulin sensitivity}}, language = {{eng}}, number = {{3}}, pages = {{211--219}}, publisher = {{Wiley-Blackwell}}, series = {{Diabetic Medicine}}, title = {{Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes}}, url = {{http://dx.doi.org/10.1111/j.1464-5491.2009.02673.x}}, doi = {{10.1111/j.1464-5491.2009.02673.x}}, volume = {{26}}, year = {{2009}}, }